View Press Releases

  • The Pistoia Alliance to Develop a Toolkit to Support Implementation of the FAIR Guiding Principles

    BOSTON, MA, UNITED STATES - Jul 17, 2019 - The Pistoia Alliance, a global non-profit that works to lower barriers to innovation in life sciences R&D, today announced the launch of its FAIR Implementation project, backed by pharmaceutical companies including Roche, Astra Zeneca, and Bayer

    Jul 17, 2019

  • Creative Diagnostics Introduces Innovative Exosome Quantification Immunoassay Kits

    SHIRLEY, NY, UNITED STATES - Jul 17, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announces that it has developed and optimized an innovative technology (ExoAssay™) that allows specific capture of exosomes from different biological samples, including cell culture supernatants and human biological fluids (plasma, serum, urine, saliva)

    Jul 16, 2019

  • BOC Sciences Improves Superparamagnetic Iron Oxide Nano/Micro Particles Preparation for Chemotherapy Research

    SHIRLEY, NY, NY, UNITED STATES - Jul 17, 2019 - Having been serving the chemical industry for nearly two decades, BOC Sciences announces to continuously improve its Superparamagnetic Iron Oxide Nano/Micro Particles Preparation service, in order to help researchers engaged with chemotherapy study find a cure for some major diseases that are inflicting the human beings

    Jul 16, 2019

  • Creative Peptides Adds an Exclusive Section for Cancer Research

    LONG ISLAND CITY, NY, UNITED STATES - Jul 17, 2019 - As one of the global leading peptide suppliers, Creative Peptides announced to add an exclusive section of peptides for researchers who are committed to exploring an effective solution for issues related to cancer research

    Jul 16, 2019

  • Rho Announces New Resource for Behavioral and Social Science Researchers to Prepare Research Protocols

    DURHAM, NC - Jul 17, 2019 -  Rho Announces New Resource for Behavioral and Social ScienceResearchers to Prepare Research ProtocolsCRO facilitated Trans-NIH committee to develop protocol template with NIDCR   Research Triangle Park, NC - July 16, 2019 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that Rho's Principal Research Scientist and Program Lead Nancy Yovetich, PhD, and Project Manager Lisa Busko  participated in a trans-NIH + extramural committee to develop a standardized protocol template for behavioral and social science researchers

    Jul 16, 2019

  • Research: State of Application Security at World's 100 Largest Banks

    BIRMINGHAM, GB - Jul 11, 2019 - Industry analysts and security practitioners unanimously concur that application security is a big deal

    Jul 11, 2019

  • Atlantic Research Group Selects Greenphire to Improve the Patient Experience for its Rare Disease and Oncology Clinical Trials

    KING OF PRUSSIA, PA, UNITED STATES - Jul 9, 2019 - Greenphire, the global leader in financial software for clinical trials, announced today that it has been selected by Atlantic Research Group (ARG), a rare and neurodegenerative disease, oncology and immunology-focused contract research organization (CRO) to implement its ClinCard and ConneX solutions to improve the clinical trial experience for sites and patients

    Jul 9, 2019

  • Certara Announces the Formation of a New Practice Area Focused on Global Health

    PRINCETON, NJ - Jul 9, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that it has formed a new practice area called Certara Global Health (CGH) to focus its technological expertise on helping to achieve equity in health for all people worldwide

    Jul 9, 2019

  • Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial

    HOUSTON, TX - Jul 8, 2019 - Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that the primary endpoint of event free survival at 180 days in its BP-004 European registration trial for rivo-cel (rivogenlecleucel) has been achieved

    Jul 8, 2019

  • PHARMASEAL Launches Second Major Release of Engility CTMS

    NOTTINGHAM, UNITED KINGDOM - Jul 8, 2019 - PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces a second major release of its Engility CTMS platform

    Jul 8, 2019

  • SEKISUI XenoTech Announces Enhanced Synergy in ADME Testing Services

    KANSAS CITY, KS, UNITED STATES - Jul 2, 2019 - SEKISUI XenoTech is collaborating with the Drug Development Solutions Center to offer a full suite of nonclinical testing services specializing in the evaluation of Absorption, Distribution, Metabolism, and Excretion (ADME) in potential new drugs

    Jul 2, 2019

  • MGI Responds to Illumina Lawsuits with Confidence in the Strength of its Patent Portfolio

    SAN JOSE, CA - Jul 2, 2019 - MGI Responds to Illumina Lawsuits with Confidence in the Strength of its Patent PortfolioCalls for Fair Competition in the Gene Sequencing Market MGI, a subsidiary of BGI Group, expressed confidence in its core patent portfolio in the field of gene sequencing and vowed to fully support the industry to achieve higher quality, more cost-effective sequencing

    Jul 2, 2019

  • Antibodies.com Raises £400,000 Pre-Seed Round to Help Researchers Discover More For Less

    , CAMBRIDGE, UNITED KINGDOM - Jul 2, 2019 - Antibodies.com, a digital marketplace that enables life scientists to purchase critical research reagents at cost-effective prices from the primary manufacturers, today announced that is has raised £400,000 in pre-seed financing

    Jul 2, 2019

  • Creative Diagnostics Launches Viral Antigens for Science Community

    SHIRLEY, NY, UNITED STATES - Jul 1, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announced that it has launched a series of viral antigens for biological research use, including Adenovirus, CMV, Coronavirus, Coxsackievirus, Dengue Virus, EBV, EV71, Ebola Virus, HAV, HBV and so on

    Jun 30, 2019

  • Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery

    BELFORD, NJ, US - Jun 28, 2019 - Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery-Contributing to both the Cancer and Inflammation and Immunity Steering Committees-SAN FRANCISCO--(BUSINESS WIRE)-- Cofactor Genomics, pioneers in the field of Predictive Immune Modeling, announced today that they have become a member of the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium with the goal of advancing the adoption of multidimensional biomarkers in cancer and immune-related diseases

    Jun 28, 2019

  • NEW MONOCLONAL ANTIBODY FOR RUBELLA TESTING AVAILABLE FROM BINDING SITE

    SAN DIEGO - Jun 28, 2019 - ~~San Diego, CA . . . . BINDING SITE'sIMMUNOLOGICALS GROUP is pleased to announce the addition of a new, purified monoclonal antibody to be used for the analysis and testing of the Rubella

    Jun 28, 2019

  • BOC Sciences Upgrades Its Product Line Specially Targeted for Life Science Research

    SHIRLEY, NY, UNITED STATES - Jun 27, 2019 - As a well-established chemical supplier based in New York, BOC Sciences announces to upgrade one of its product lines specially targeted for life science research, including small molecules in stem cell, carbohydrates, nucleosides & nucleotides as well as fluorescent probes

    Jun 26, 2019

  • X4 Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Mavorixafor for the Treatment of WHIM Syndrome

    CAMBRIDGE, MA, US - Jun 26, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the initiation of 4WHIM, a pivotal Phase 3 global clinical trial of mavorixafor (X4P-001) for the treatment of WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome, a rare, inherited, primary immunodeficiency disease

    Jun 26, 2019

  • Creative Biolabs Provides Diabody Service to Customers for Research Use

    ACCORD, NY - Jun 25, 2019 - June 25, 2019, as one of the most successful suppliers in the field of antibody production, Creative Biolabs developed diabody service to customers for both academic and clinical research use

    Jun 25, 2019

  • Genedata Expands Collaboration with AstraZeneca on Deep Learning for High-Content Image Analysis

    BASEL, SWITZERLAND - Jun 25, 2019 - Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced a collaboration with AstraZeneca to automate high-content screening (HCS) image analysis using Genedata Imagence®

    Jun 25, 2019